2021 Speakers

Chris Scott_edited.jpg


Kidney Transplant in Vasculitis

Professor Stephen Marks, MD MSc MRCP DCH FRCPCH is Professor of Paediatric Nephrology and Transplantation at University College London Great Ormond Street Institute of Child Health. He is clinical
lead for renal transplantation and Director of the National Institute for Health Research Great Ormond Street Hospital Clinical Research Facility at Great Ormond Street Hospital for Children NHS Foundation Trust. He is currently chair of the British Association for Paediatric Nephrology and UK Renal Registry Audit and Informatics committee having previously been the chair of the National Health Service Blood and Transplant Paediatric Kidney Advisory Group. He has extensive clinical and academic interest in vasculitis, juvenile onset systemic lupus erythematosus and lupus nephritis having been expert advisor for ERA-EDTA, EULAR and SHARE recommendations. In addition, his
research continues to date in the field of renal transplantation (including innovative drug trials). He is on the editorial board for “British Journal of Renal Medicine” and is associate editor for “Transplantation”, “Pediatric Nephrology” and “Pediatric Transplantation”, which are the journals of
The Transplantation Society, the International Pediatric Nephrology Association and the International Pediatric Transplant Association (IPTA) respectively. Having been chair of the Publications and Communications Committee, he is now a Councillor of IPTA.

Kelly Brown


Infection Prevention in Vasculitis

Dr Jessica Dunn is a pediatric infectious diseases physician at Alberta Children’s Hospital and Clinical Assistant Professor in the Department of Pediatrics at the University of Calgary.   She completed her medical degree and Master of Public Health at Boston University, followed by pediatric and infectious diseases post-graduate training at the University of Ottawa.  She is a member of the ACHIEVE Research Team and one of the infection control physicians at ACH.  Her greatest clinical interest is congenital infections, particularly congenital CMV. 

Cape Town, South Africa

KEYNOTE PRESENTATION: An overview of Takayasu in South Africa and the link to Tuberculosis

Dr. Scott is Associate Professor and head of Paediatric Rheumatology at the Red Cross War Memorial Children’s Hospital and the University of Cape Town. His research and educational focus is on the care of patients with rare and rheumatic diseases in Africa and other less resourced communities. Professor Scott has a special interest in access to care, paediatric vasculitis, SLE, juvenile idiopathic arthritis and fibrodysplasia ossificans progressiva. He is the former chairman of the South African Arthritis Foundation and the co-chair of the Global Task Force for Musculoskeletal Health Task Force. He also serves on the Steering committee of the Paediatric Society of the African League of Associations for Rheumatology, the International Clinical Council for Fibrodysplasia Ossificans Progressiva (FOP) and the Presidents Council for the International Fibrodysplasia Ossificans Progressiva Association (IFOPA).

Stephen Marks


Different endotypes of chronic primary systemic vasculitis affecting small-to-medium sized vessels: a new approach to classification

Dr. Kelly Brown studied biochemistry (B.Sc) at Simon Fraser University (Burnaby, Canada), immunology (Ph.D.) at the University of British Columbia, and performed postdoctoral studies (in systems biology, functional genomics, and phagocyte biology) at the Child & Family Research Institute in Vancouver, Canada, the Wellcome Trust Sanger Institute in Cambridge, UK and The University of Gothenburg in Gothenburg, Sweden. She is currently an Assistant Professor in the Department of Pediatrics, Division of Rheumatology at the University of British Columbia. Her laboratory is located on the the campus of the BC Children’s Hospital in the BC Children’s Hospital​ Research Institute. She and her team are interested in understanding immunological drivers and subclinical markers of vasculitis and other rheumatic diseases with the eventual goal of using this knowledge to improve current clinical assessment and scoring tools.

Jessica Dunn_headshot_edited.jpg